Related Experiment Video
Updated: Aug 6, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Impact of sex assigned at birth and HIV acquisition route on long-acting cabotegravir plus rilpivirine persistence: A
Maria Vittoria Cossu1, Andrea Giacomelli2, Letizia Oreni1
1Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.
Background:
Despite growing adoption of long-acting antiretroviral therapy, real-world data on sex-related differences in treatment persistence remain limited.
Methods:
Retrospective single-center cohort study of virologically suppressed people with HIV (PWH) initiating long-acting cabotegravir plus rilpivirine (CAB + RPV LA) between September 2022 and September 2025 in Milan, Italy. Kaplan-Meier and Cox regression models, adjusted for confounders, assessed the association between sex assigned at birth (SAB), alone and jointly with HIV acquisition route, and treatment discontinuation.
Results:
Among 289 PWH (58 females, 20.1%), with a median follow-up of 28.8 months, 36 (12.4%) discontinued treatment. Female SAB was associated with higher discontinuation rates compared with male SAB (25.9% vs 9.1%) and independently predicted treatment discontinuation (adjusted hazard ratio [aHR] 2.56). Males who have sex with males (MSM) had a lower risk of discontinuation compared with heterosexual females (aHR 0.36), while no difference was observed between MSM and heterosexual males. Injection site reactions, logistical barriers, and pregnancy were the main reasons for discontinuation among females. Virological failure was uncommon overall (1%).
Conclusion:
Female SAB was associated with higher CAB + RPV LA discontinuation rates, potentially reflecting a complex interplay of biological, reproductive, and socio-structural factors, supporting the need for sex- and gender-informed support strategies when initiating CAB + RPV LA.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Amebiasis
Antiviral Nucleoside Inhibitors
Therapeutic Drug Monitoring: Affecting Factors
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
